Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Telephone and Data: A Study in Contrasts Amid Fiber Expansion

Andreas Sommer by Andreas Sommer
September 17, 2025
in Analysis, Telecommunications, Turnaround
0
Telephone and Data Stock
0
SHARES
116
VIEWS
Share on FacebookShare on Twitter

Telephone and Data presents a compelling investment paradox. The company finds itself navigating a landscape where bullish analyst upgrades coexist with persistent financial losses. The central question for investors is whether the company’s aggressive fiber optic infrastructure expansion can ultimately transform its financial trajectory.

Mixed Signals from Market Analysts

The analyst community remains cautiously divided on the telecommunications firm’s prospects. While Zacks Research has marginally improved its first-quarter 2026 forecast—narrowing the expected per-share loss from $0.05 to $0.04—the firm maintains its “Hold” recommendation. Market consensus continues to project an annual loss of $0.31 per share for 2026.

Contrasting this cautious stance, several prominent institutions have recently increased their price targets. Raymond James raised its target from $49 to $50 while maintaining an “Outperform” rating. JPMorgan Chase followed a similar pattern, boosting its target from $53 to $54 and reaffirming its “Overweight” recommendation. In a notable shift, Wall Street Zen upgraded its rating from “Sell” to “Hold.” The current analyst consensus stands at “Moderate Buy” with an average price target of $52.

Dividend Consistency at Reduced Levels

Shareholders will receive a dividend payment of $0.04 per share on September 30, maintaining the same rate as previous distributions. However, this payout remains substantially below the company’s ten-year historical average of approximately $0.14 per share. This dividend policy suggests management is balancing shareholder returns with other strategic priorities, particularly the capital-intensive fiber network deployment.

Should investors sell immediately? Or is it worth buying Telephone and Data?

Insider Trading and Short Interest Dynamics

Recent trading activity among corporate insiders has drawn market attention. Chief Administrative Officer Anita J. Kroll disposed of shares valued at over $336,000 in late August, executing transactions at an average price of $39.09 per share. Over the past ninety days, company executives have collectively sold more than 276,000 shares worth nearly $10.7 million.

Simultaneously, the short interest ratio has declined by 16.6 percent, potentially indicating reduced bearish sentiment among speculative investors. This combination of insider selling and decreasing short positions creates an ambiguous market signal that requires careful interpretation.

Fiber Infrastructure: The Potential Growth Catalyst

The most significant development supporting optimistic analyst assessments involves TDS Telecom, a subsidiary of Telephone and Data. The company recently surpassed one million fiber service addresses, marking a substantial milestone in its infrastructure expansion program. This extensive network build-out could potentially enhance long-term profitability and strengthen the company’s competitive position within the telecommunications sector.

Currently trading at €38.00, the company’s shares have demonstrated notable recovery from their 52-week low of €22.81, though they remain approximately 7 percent below their yearly peak. The critical investment consideration remains whether Telephone and Data can successfully convert its substantial fiber investments into sustainable profitability and shareholder value.

Ad

Telephone and Data Stock: Buy or Sell?! New Telephone and Data Analysis from February 7 delivers the answer:

The latest Telephone and Data figures speak for themselves: Urgent action needed for Telephone and Data investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Telephone and Data: Buy or sell? Read more here...

Tags: Telephone and Data
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

CrossFirst Bankshares Stock
Analysis

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Myers Industries Stock
Analysis

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
Riley Exploration Permian Stock
Analysis

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

February 7, 2026
Next Post
Nautilus Biotechnology Stock

CEO's Major Investment Signals Confidence in Nautilus Biotechnology

Blacksky Technology Stock

BlackSky Shares Decline Despite Major Intelligence Contract Win

Bel Fuse Stock

Bel Fuse Shares Surge on Major Wall Street Upgrade

Recommended

Super Micro Computer Stock

Super Micro Stock Surges Amid AI Infrastructure Boom

4 months ago
Adobe Stock

Adobe’s AI Ambitions Face Investor Skepticism

4 months ago
IBM Stock

Strong IBM Earnings Fail to Impress Market as Key Segment Shows Weakness

4 months ago
Inozyme Pharma Inc Stock

Inozyme Pharma Acquisition Finalized: Strategic Focus Shifts to Clinical Development

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

Great Lakes Dredge & Dock: A Cash Flow Inflection Point Approaches

Investors Await March Report for Boston Omaha’s Strategic Direction

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

Trending

Orthofix Medical Stock
Earnings

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

by Rodolfo Hanigan
February 7, 2026
0

Investor attention turns to Orthofix Medical as the company bolsters the clinical support for its biologics business...

CrossFirst Bankshares Stock

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Golden Entertainment Stock

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

February 7, 2026
Myers Industries Stock

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
OneSpan Stock

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio
  • A New Chapter for First Busey as CrossFirst Merger Finalizes
  • Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com